NEVVI Medicare utilization intelligence
or

← back

Provider profile

NGUYEN, PHONG MD

Rheumatology · NPI 1699836726 · RESTON, VA

2
Groups
31
Codes · 2024
532,012
Disclosed services

NGUYEN, PHONG is a Rheumatology in RESTON, VA, a member of 2 medical groups, who billed 31 distinct codes to Medicare Part B in 2024.

Groups: AMERICAN ARTHRITIS AND RHEUMATOLOGY ASSOCIATES DC PC (RESTON, VA) · AMERICAN ARTHRITIS AND RHEUMATOLOGY ASSOCIATES VA LLC (COLONIAL HEIGHTS, VA) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

532,012
disclosed services
31
codes billed to Medicare Part B
Prior year · CY2023 468,766 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J3262 Injection, tocilizumab, 1 mg
J3111 Injection, romosozumab-aqqg, 1 mg
J0897 Injection, denosumab, 1 mg
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1602 Injection, golimumab, 1 mg, for intravenous use
J1745 Injection, infliximab, excludes biosimilar, 10 mg
J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
96413 Administration of chemotherapy into vein, 1 hour or less
J2919 Injection, methylprednisolone sodium succinate, 5 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
20610 Aspiration and/or injection of fluid from large joint
J1010 Injection, methylprednisolone acetate, 1 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J7324 Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
96415 Administration of chemotherapy into vein, each additional hour
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
J3489 Injection, zoledronic acid, 1 mg
96375 Injection of additional new drug or substance into vein
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
J1030 Injection, methylprednisolone acetate, 40 mg
20605 Aspiration and/or injection of fluid from medium joint
20600 Aspiration and/or injection of fluid from small joint
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.